Cargando…

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C

The closely related inhibitory killer-cell immunoglobulin-like receptors (KIR), KIR2DL2 and KIR2DL3, regulate the activation of natural killer cells (NK) by interacting with the human leukocyte antigen-C1 (HLA-C1) group of molecules. KIR2DL2, KIR2DL3 and HLA-C1 are highly polymorphic, with this vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moradi, Shoeib, Stankovic, Sanda, O’Connor, Geraldine M., Pymm, Phillip, MacLachlan, Bruce J., Faoro, Camilla, Retière, Christelle, Sullivan, Lucy C., Saunders, Philippa M., Widjaja, Jacqueline, Cox-Livingstone, Shea, Rossjohn, Jamie, Brooks, Andrew G., Vivian, Julian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041999/ https://www.ncbi.nlm.nih.gov/pubmed/33846289 http://dx.doi.org/10.1038/s41467-021-22359-x

Ejemplares similares

KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
por: Tapsoba, Aziz Sidi Aristide, et al.
Publicado: (2022)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC
por: Lisovsky, Irene, et al.
Publicado: (2019)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
por: Morales, Raquel, et al.
Publicado: (2023)

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells
por: Sim, Malcolm J. W., et al.
Publicado: (2015)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Peptide selectivity discriminates NK cells from KIR2DL2‐ and KIR2DL3‐positive individuals
por: Cassidy, Sorcha, et al.
Publicado: (2014)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
por: Chrul, Slawomir, et al.
Publicado: (2006)

Deciphering the biology of KIR2DL3(+) T lymphocytes that are associated to relapse in haploidentical HSCT
por: David, Gaëlle, et al.
Publicado: (2021)

Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
por: Niepiekło-Miniewska, Wanda, et al.
Publicado: (2014)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients
por: Sezgin, Gülay, et al.
Publicado: (2022)

KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation
por: Legaz, Isabel, et al.
Publicado: (2019)

A novel full‐length two‐domain KIR2DL5A allele isolated in Zimbabwean samples: KIR2DL5A*0010104
por: van Pul, Lisa, et al.
Publicado: (2020)

KIR and HLA haplotype analysis in a family lacking the KIR 2DL1-2DP1 genes
por: Vojvodić, S, et al.
Publicado: (2015)

KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles
por: Bari, Rafijul, et al.
Publicado: (2016)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
por: La, David, et al.
Publicado: (2011)

Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression
por: Wright, Paul W., et al.
Publicado: (2014)

The KIR2DL1 intermediate upstream element participates in gene activation
por: Wright, Paul W., et al.
Publicado: (2023)

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
por: Erbe, Amy K., et al.
Publicado: (2019)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
por: Euchner, Johanna, et al.
Publicado: (2021)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
Publicado: (2017)

KIR2DL4 (CD158d): An activation receptor for HLA-G
por: Rajagopalan, Sumati, et al.
Publicado: (2012)

Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
por: Zheng, Guoxu, et al.
Publicado: (2022)

Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma
por: Bortolotti, Daria, et al.
Publicado: (2022)

Regulation of KIR3DL3 Expression via miRNA
por: Nutalai, Rungtiwa, et al.
Publicado: (2019)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
por: Hirayasu, Kouyuki, et al.
Publicado: (2012)

Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide Sensitivity
por: O’Connor, Geraldine M., et al.
Publicado: (2014)

KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression
por: Cisneros, Elisa, et al.
Publicado: (2012)

Homozygous KIR2DL3 confers susceptibility to tuberculosis infection in HIV seropositive individuals
por: Maruthamuthu, Stalinraja, et al.
Publicado: (2014)

The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis
por: Nishimura, Wester Eidi, et al.
Publicado: (2015)

Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas
por: Schmitt, Christian, et al.
Publicado: (2017)

KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth
por: Anastasaki, Corina, et al.
Publicado: (2017)

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes
por: Falco, Michela, et al.
Publicado: (2022)

Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression
por: Niu, Chao, et al.
Publicado: (2018)

Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity
por: Bortolotti, Daria, et al.
Publicado: (2022)

In vitro education of human natural killer cells by KIR3DL1
por: Pugh, Jason, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k6kgrbsegeoul2so7ucsodnh5i